MCKINLEY CAPITAL MANAGEMENT LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 298 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
MCKINLEY CAPITAL MANAGEMENT LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$39,000
+5.4%
1,1020.0%0.00%0.0%
Q4 2018$37,000
-68.6%
1,102
-52.9%
0.00%
-57.1%
Q3 2018$118,000
-22.4%
2,340
-7.8%
0.01%
-30.0%
Q2 2018$152,000
+22.6%
2,539
-6.5%
0.01%
+42.9%
Q1 2018$124,000
-96.0%
2,716
-96.5%
0.01%
-95.6%
Q4 2017$3,132,000
-0.3%
78,586
+0.1%
0.16%
+23.4%
Q3 2017$3,141,000
-45.5%
78,531
-41.3%
0.13%
-40.7%
Q2 2017$5,763,000
+5.1%
133,722
-23.7%
0.22%
+7.5%
Q1 2017$5,485,000
+24.0%
175,240
+0.0%
0.20%
+15.5%
Q4 2016$4,423,000
-43.3%
175,170
-44.5%
0.17%
-38.1%
Q3 2016$7,801,000
-8.4%
315,444
-24.5%
0.28%
-31.8%
Q2 2016$8,513,000
+22.1%
417,898
-8.6%
0.41%
+22.3%
Q1 2016$6,974,000
+42.2%
457,335
+25.4%
0.34%
+48.5%
Q4 2015$4,903,000
-4.1%
364,794
+0.1%
0.23%
-8.8%
Q3 2015$5,115,000
-17.4%
364,543
-0.1%
0.25%
-6.0%
Q2 2015$6,194,000364,7840.26%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders